Trials / Unknown
UnknownNCT02908438
Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Northwest Women's and Children's Hospital, Xi'an, Shaanxi · Academic / Other
- Sex
- Female
- Age
- 18 Years – 37 Years
- Healthy volunteers
- Not accepted
Summary
The study was designed to investigate the effect of luteal-phase administration of gonadotrophin releasing hormone agonist(GnRHa) on pregnancy outcomes in in-vitro fertilization-embryo transfer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gonadotrophin releasing hormone agonist(GnRHa) | GnRHa group receive three injections of GnRHa(Decapeptyl) ,0.1 mg s.c. on the day of ET, and D3 and D6 after ET in addition to routine LPS. |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-09-01
- First posted
- 2016-09-21
- Last updated
- 2016-09-21
Source: ClinicalTrials.gov record NCT02908438. Inclusion in this directory is not an endorsement.